Aflatoxin B1 negatively regulates Wnt/β-catenin signaling pathway through activating miR-33a

Yi Fang1, Youjun Feng, Tongjin Wu

  • 1The Ministry of Education Key Laboratory of Biopesticide and Chemical Biology and the College of Life Sciences, Fujian Agriculture and Forestry University, Fuzhou, P. R. China ; Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, P. R. China ; Fujian Key Laboratory of Integrative Medicine on Geriatrics, Fujian University of Traditional Chinese Medicine, Fuzhou, P. R. China.

Plos One
|September 10, 2013
PubMed

Insights

Aflatoxin B1 (AFB1) exposure increases microRNA-33a (miR-33a) levels, which then decrease beta-catenin expression in liver cancer cells. This novel AFB1-miR-33a-beta-catenin pathway offers potential therapeutic targets for cancer treatment.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Toxicology

Background:

  • MicroRNAs regulate gene expression in diseases like cancer.
  • Aflatoxin B1 (AFB1) is a potent mycotoxin linked to various health issues.
  • The role of microRNAs in AFB1-induced pathology is not well understood.

Purpose of the Study:

  • To investigate the regulatory network between AFB1, miR-33a, and beta-catenin in human carcinoma cells.
  • To elucidate the mechanism by which AFB1 affects beta-catenin expression.
  • To explore the potential of miR-33a as a therapeutic target in cancer.

Main Methods:

  • Treatment of hepatocellular carcinoma (HCC) cells with AFB1.
  • Quantification of miR-33a and beta-catenin expression levels.
  • Luciferase assay to confirm direct binding of miR-33a to beta-catenin.
  • Analysis of the beta-catenin pathway and cell growth inhibition.

Main Results:

  • AFB1 up-regulated miR-33a levels in HCC cells.
  • miR-33a down-regulated beta-catenin expression and affected the beta-catenin pathway.
  • miR-33a directly bound to the 3'-UTR of beta-catenin, inhibiting cell growth.
  • AFB1 potentially down-regulates beta-catenin by up-regulating miR-33a.

Conclusions:

  • A novel regulatory network involving AFB1, miR-33a, and beta-catenin in human carcinoma cells was discovered.
  • miR-33a acts as a tumor suppressor by down-regulating beta-catenin.
  • This finding provides new insights into the role of miR-33a in cancer therapy.

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Catenins01:23

Catenins

Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...